Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing
Citations Over TimeTop 10% of 2013 papers
Abstract
Oncogenic fusion genes that involve kinases have proven to be effective targets for therapy in a wide range of cancers. Unfortunately, the diagnostic approaches required to identify these events are struggling to keep pace with the diverse array of genetic alterations that occur in cancer. Diagnostic screening in solid tumours is particularly challenging, as many fusion genes occur with a low frequency. To overcome these limitations, we developed a capture enrichment strategy to enable high-throughput transcript sequencing of the human kinome. This approach provides a global overview of kinase fusion events, irrespective of the identity of the fusion partner. To demonstrate the utility of this system, we profiled 100 non-small cell lung cancers and identified numerous genetic alterations impacting fibroblast growth factor receptor 3 (FGFR3) in lung squamous cell carcinoma and a novel ALK fusion partner in lung adenocarcinoma.
Related Papers
- → Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma(2012)772 cited
- → A novel MAP3K7CL‐ERG fusion in a molecularly confirmed case of dermatofibrosarcoma protuberans with fibrosarcomatous transformation(2019)27 cited
- → EWSR1‐PBX3: A novel gene fusion in myoepithelial tumors(2014)103 cited
- → A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants(2008)16 cited
- → Letter to the Editor: Detection of EML4-ALK and Other ALK Fusion Genes in Lung Cancer: A Lesson from the Leukemia Fusion Gene Analysis and Future Application(2012)